Predicting time on the waiting list for HLA matched corneal grafts

被引:15
作者
Böhringer, D
Reinhard, T
Böhringer, S
Enczmann, J
Godehard, E
Sundmacher, R
机构
[1] Univ Dusseldorf, Univ Hosp, Hosp Eye, D-4000 Dusseldorf, Germany
[2] Univ Dusseldorf, Univ Hosp, LIONS Cornea Bank N Rhine Westphalia, D-4000 Dusseldorf, Germany
[3] Ruhr Univ Bochum, Inst Human Genet, Bochum, Germany
[4] Univ Dusseldorf, Univ Hosp, Inst Transplantat Immunol, D-4000 Dusseldorf, Germany
[5] Univ Dusseldorf, Univ Hosp, Clin Cardiac & Thorac Surg, D-4000 Dusseldorf, Germany
来源
TISSUE ANTIGENS | 2002年 / 59卷 / 05期
关键词
HLA matching; immune reaction; keratoplasty; matchability; simulation; waiting period;
D O I
10.1034/j.1399-0039.2002.590507.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recent studies report the beneficial effect of HLA matching for the long-term prognosis of penetrating keratoplasty (KP). This improvement in prognosis, however, has to be weighed against the additional waiting time while a HLA compatible graft is found. Precise estimation of this additional waiting period is a prerequisite for informed consent on the waiting policy. A mathematical model based on survival analysis and HLA haplotype frequencies was used to estimate time on the waiting list for each of 1400 HLA typed patients registered at the Lions Cornea Bank North Rhine Westfalia (NRW). Additionally, the waiting period for each patient was retrospectively determined. Both values were tested for correlation. This analysis was performed for acceptance of up to two mismatches on HLA-A, -B and -DR. The median predicted waiting period was compatible with the median waiting period in retrospective simulation. Correlation of both entities was statistically significant also. Predicted time on the waiting list as derived from the patient's HLA genotype and a comprehensive database of HLA haplotype frequencies is thus a valuable tool for management of HLA-matching in KP.
引用
收藏
页码:407 / 411
页数:5
相关论文
共 17 条
  • [1] MATCHABILITY IN KIDNEY-TRANSPLANTATION
    GILKS, WR
    GORE, SM
    BRADLEY, BA
    [J]. TISSUE ANTIGENS, 1988, 32 (03): : 121 - 129
  • [2] PREDICTING MATCH GRADE AND WAITING TIME TO KIDNEY-TRANSPLANTATION
    GILKS, WR
    GORE, SM
    BRADLEY, BA
    [J]. TRANSPLANTATION, 1991, 51 (03) : 618 - 624
  • [3] HILL JC, 1994, OPHTHALMOLOGY, V101, P128
  • [4] AORTIC OBSTRUCTIONS IN INFANTS AND CHILDREN - SURGERY FOR INTERRUPTED AORTIC-ARCH
    HOFF, SJ
    MERRILL, WH
    BENDER, HW
    [J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 1994, 3 (02) : 100 - 105
  • [5] MELS L, 2000, EUROPEAN EY BANK ASS, P8
  • [6] Niederkorn JY, 1996, INVEST OPHTH VIS SCI, V37, P2700
  • [7] Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis
    Ohta, K
    Wiggert, B
    Yamagami, S
    Taylor, AW
    Streilein, JW
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (03) : 1185 - 1192
  • [8] Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A
    Reinhard, T
    Möller, M
    Sundmacher, R
    [J]. CORNEA, 1999, 18 (06) : 645 - 651
  • [9] Mycophenolate mofetil in high-risk penetrating keratoplasty. A pilot study
    Reinhard, T
    Reis, A
    Kutkuhn, B
    Voiculescu, A
    Sundmacher, R
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1999, 215 (03) : 201 - 202
  • [10] Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk
    Reinhard, T
    Hutmacher, M
    Sundmacher, R
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1997, 210 (03) : 139 - 143